- Judge to sentence Trump before inauguration in hush money case
- Microsoft expects to spend $80 bn on AI this fiscal year
- AC Milan rally past Juventus to meet Inter in Italian SuperCup final
- Trump-backed Republican Johnson elected speaker of US House
- Gaza rescuers say about 30 killed as truce talks resume
- UK, Germany electricity cleanest on record in 2024
- Oil from Russian tanker spill reaches Sevastopol
- Man arrested for supplying drugs to Liam Payne: Argentine police
- US House rejects Trump-backed speaker in first ballot
- European ministers urge inclusive transition on Syria visit
- Rickelton hits Test best as South Africa on top against Pakistan
- Lebanon minister says working to 'resolve' Syria's new entry restrictions
- US announces $306 mn in new bird flu funding
- Salah targets Premier League glory in 'last year' at Liverpool
- Rockets fired from Gaza as Israeli strikes kill 16, rescuers say
- Marseille coach De Zerbi defends 'strong' Ligue 1
- Rickelton, Bavuma tons put South Africa in strong position
- Breeding success: London zoo counts its animals one-by-one
- Fofana could miss rest of Chelsea's season
- Republican speaker, Trump face test in Congress leadership fight
- Man Utd 'starving for leaders' ahead of Liverpool clash: Amorim
- Alcohol should have cancer warning label: US surgeon general
- Biden blocks US Steel sale to Japan's Nippon Steel
- Wall Street stocks bounce higher, Europe retreats
- Neil Young says he will play Glastonbury after all
- Frenchman Castera plots roadmap for Dakar success
- Doha hosts PSG clash with Monaco in French Champions Trophy
- Hamilton 'excited for year ahead' after Ferrari switch
- Man City must 'think' about De Bruyne future: Guardiola
- Biden blocks US-Japan steel deal
- French police to face trial for 'suffocating' death
- British novelist David Lodge dies aged 89
- Indonesia says 2024 was hottest year on record
- South African Lategan wins Dakar Rally prologue
- Barca coach Flick optimistic but 'not happy' over Olmo situation
- Djokovic Australian Open preparations take hit with loss to Opelka
- Indian duo self-immolate in Bhopal waste protest
- Indian food delivery app rolls out ambulance service
- Arsenal must 'flip coin' in Premier League title race, says Arteta
- European stock markets retreat after positive start to year
- World food prices dip 2% in 2024: FAO
- The horror of Saydnaya jail, symbol of Assad excesses
- Sabalenka sets up Brisbane semi against Russian teen Andreeva
- Top European diplomats urge inclusive transition in Syria visit
- Liverpool's Slot says Man Utd 'much better' than league table shows
- UK electricity cleanest on record in 2024: study
- Rampant Czechs set up United Cup semi-final against US
- Rohit omission from decisive Test 'emotional' says India's Pant
- Beijing slams US over potential Chinese drone ban
- Blinken to visit South Korea with eye on political crisis
Lab-grown human 'embryos' offer new research hope
Scientists have developed human embryo-like structures without using sperm, an egg or fertilisation, offering hope for research on miscarriage and birth defects but also raising fresh ethical concerns.
Earlier this year, several labs around the world released pre-print studies describing their development of early human embryo-like structures.
That work has not yet been peer-reviewed, but now one group's research has been published in the journal Nature, describing how they coaxed human embryonic stem cells to self-organise into a model resembling an early embryo.
The research was welcomed by some scientists as an "impressive" advance that could help unlock secrets about the precarious early stages of pregnancies, when failure is most common.
The work will however renew debate on the need for clearer ethical rules on development of lab-grown human embryo models.
The researchers, led by Palestinian scientist Jacob Hanna at the Weizmann Institute in Israel, harnesses the power of embryonic stem cells, which can become any kind of cell.
They produced embryo models up to 14 days old, which is the legal limit for such research in many countries, and the point at which organs like the brain begin to develop.
The researchers say their work differs from those of other teams because it uses chemically rather than genetically modified embryonic stem cells and produces models more like real human embryos, complete with yolk sac and amniotic cavity.
These similarities could make the models more useful for research into conditions like miscarriage, birth defects and infertility, said James Briscoe of Britain's Francis Crick Institute.
The model "seems to produce all of the different types of cells that form tissues at this early stage of development," said Briscoe, principal group leader and associate research director at the biomedical research charity.
The research "is a step towards opening a window on the period of human development where many pregnancies fail and which has been really difficult to study up until now."
Both the researchers and scientists not involved in the work emphasised that the models should not be considered human embryos.
The structure "highly resembles, but (is) not identical, to the in utero situation", the research notes.
The success rate on generating the models was also low, with the stem cells organising correctly just a small percentage of the time.
Still, the research and other recent work shows "that models of human embryos are getting more sophisticated and closer to events that occur during normal development," said Darius Widera, an expert in stem cell biology at the UK's University of Reading.
The work highlights "that a robust regulatory framework is more needed than ever before", he added.
In Britain, Cambridge University has begun developing the first governance framework for stem cell-based human embryo models.
The Weizmann Institute research does not involve transferring the models into a human or animal womb, or developing the structures beyond 14 days.
P.Martin--AMWN